<!DOCTYPE html>

<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Next-Gen Patient Avatar & AI Predictive Models</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <style>
        body {
            background: linear-gradient(145deg, #0f172a, #1e293b);
            color: #e2e8f0;
        }
        .glass {
            background: rgba(255, 255, 255, 0.05);
            backdrop-filter: blur(10px);
            border: 1px solid rgba(255, 255, 255, 0.1);
        }
        .tech-border {
            border-image: linear-gradient(90deg, #06b6d4, #8b5cf6) 1;
            border-width: 2px;
            border-style: solid;
        }
    </style>
</head>

<body class="font-sans leading-normal tracking-normal">

    <!-- Header -->
    <header class="bg-gradient-to-r from-cyan-700 to-purple-800 text-white shadow-lg">
        <nav class="container mx-auto px-6 py-4 flex justify-between items-center">
            <img src="images/logo-white.png" alt="aiPTO Logo" class="h-10">
            <ul class="flex">
                <li class="mx-3"><a href="#" class="hover:text-cyan-200">Home</a></li>
                <li class="mx-3"><a href="#about" class="hover:text-cyan-200">About</a></li>
                <li class="mx-3"><a href="#news" class="hover:text-cyan-200">News</a></li>
                <li class="mx-3"><a href="#contact" class="hover:text-cyan-200">Contact</a></li>
            </ul>
        </nav>
    </header>

    <!-- Hero Section -->
    <section class="text-center py-20">
        <div class="container mx-auto">
            <h2 class="text-5xl font-bold text-white">Revolutionize Brain Cancer Therapy</h2>
            <p class="mt-6 text-xl text-blue-200 max-w-2xl mx-auto">Merging AI and biology to create personalized avatars and next-gen therapeutic predictions.</p>
        </div>
    </section>

    <!-- About Section -->
    <section id="about" class="py-20">
        <div class="container mx-auto px-6">
            <div class="glass p-8 rounded-lg shadow-xl">
                <h3 class="text-3xl font-bold mb-6 text-cyan-300">About aiPTO</h3>
                <p class="text-blue-100 mb-6">aiPTO Solutions harnesses cutting-edge artificial intelligence and biomimetic modeling to replicate tumor microenvironments at a molecular level. These digital twins enable rapid prediction of patient-specific treatment responses, unlocking personalized therapeutic design and real-time drug resistance solutions.</p>
                <img src="images/IPTO.jpg" alt="Patient Avatar Histology" class="rounded-xl shadow-2xl border-4 border-cyan-500 mx-auto max-w-xl">
                <p class="text-sm text-blue-400 mt-4 text-center">Visualized immune-tumor interactions from patient-derived models.</p>
            </div>
        </div>
    </section>

    <!-- News Section -->
    <section id="news" class="py-20">
        <div class="container mx-auto px-6">
            $1
<div class="glass p-6 rounded-lg">
    <h4 class="text-xl font-semibold text-white">New Perspectives for Brain Tumor Therapy</h4>
    <p class="text-blue-200">February 2025 - DKFZ highlights a major breakthrough in brain tumor therapy through the publication of an individualized patient-derived brain organoid model. This innovation paves the way for personalized treatment of aggressive brain tumors such as glioblastoma. <a href="https://www.dkfz.de/en/news/press-releases/detail/new-perspectives-for-personalized-therapy-of-brain-tumors" class="text-cyan-400 underline" target="_blank">Read more on DKFZ</a></p>
</div>
            <div class="glass p-6 rounded-lg">
                    <h4 class="text-xl font-semibold text-white">Breakthrough Brain Cancer Avatar Model Published</h4>
                    <p class="text-blue-200">February 2025 - aiPTO celebrates the publication of pioneering research by scientific co-founder Prof. Haikun Liu, presenting the first brain cancer avatar model capable of predicting patient responses. This patient-derived organoid platform, integrated with aiPTO's generative AI, is transforming brain cancer precision medicine and drug development. <a href="https://www.linkedin.com/posts/dkfz-de_brain-tumor-organoid-activity-7295368974081445889-6A_B?utm_source=share&utm_medium=member_desktop&rcm=ACoAAANapYsBaxKA9hpf53ivGUTGtIr2C9QuHw8" class="text-cyan-400 underline" target="_blank">View LinkedIn post</a> &nbsp;|&nbsp; <a href="https://www.dkfz.de/en/news/press-releases/detail/new-perspectives-for-personalized-therapy-of-brain-tumors" class="text-cyan-400 underline" target="_blank">Read perspectives on DKFZ</a></p>
                </div>
                
                
                <div class="glass p-6 rounded-lg">
                    <h4 class="text-xl font-semibold text-white">aiPTO Spin-Off Announced by DKFZ</h4>
                    <p class="text-blue-200">December 2024 - DKFZ officially announces the spin-off of aiPTO, a next-generation techbio startup leveraging AI and organoid technology to revolutionize brain cancer therapy. <a href="https://www.linkedin.com/posts/dkfz-innovation_innovation-cancerresearch-braincancer-activity-7274709937778241537-JtsR?utm_source=share&utm_medium=member_desktop&rcm=ACoAAANapYsBaxKA9hpf53ivGUTGtIr2C9QuHw8" class="text-cyan-400 underline" target="_blank">View LinkedIn post</a></p>
                </div>
            </div>
        </div>
    </section>

    <!-- Contact Section -->
    <section id="contact" class="py-20">
        <div class="container mx-auto px-6">
            <h3 class="text-3xl font-bold mb-6 text-cyan-300">Connect with Us</h3>
            <div class="glass w-full max-w-lg p-6 rounded-lg mx-auto text-center">
                <p class="text-blue-100 text-lg mb-6">Send us an email at <a href="mailto:contact@aiptobio.com" class="text-cyan-400 underline">contact@aiptobio.com</a></p>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="bg-gray-900 text-blue-300 text-center py-4">
        <p>Â© 2025 aiPTO Solutions. Empowering the future of medicine.</p>
    </footer>

</body>
</html>
